Page last updated: 2024-08-24

plerixafor and Hepato-Pulmonary Syndrome

plerixafor has been researched along with Hepato-Pulmonary Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, B; Gu, JT; Lu, KZ; Ning, JL; Shen, CC; Yi, B; Zeng, J	1

Other Studies

1 other study(ies) available for plerixafor and Hepato-Pulmonary Syndrome

Article	Year
AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:3 Topics: Animals; Benzylamines; Cells, Cultured; Common Bile Duct; Cyclams; Down-Regulation; Hepatopulmonary Syndrome; Heterocyclic Compounds; Ligation; Lung; Male; Neovascularization, Pathologic; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Signal Transduction	2018

Article

Year

AMD3100 treatment attenuates pulmonary angiogenesis by reducing the c-kit (+) cells and its pro-angiogenic activity in CBDL rat lungs.

Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:3

Topics: Animals; Benzylamines; Cells, Cultured; Common Bile Duct; Cyclams; Down-Regulation; Hepatopulmonary Syndrome; Heterocyclic Compounds; Ligation; Lung; Male; Neovascularization, Pathologic; Proto-Oncogene Proteins c-kit; Rats; Rats, Sprague-Dawley; Signal Transduction

2018